Selank
Brain & neurobiology
Early humanSmall comparative Russian studies in anxiety/neurasthenia and phobic anxiety and somatoform disorders have been published, alongside animal, receptor, and gene expression work.
Limited, exploratory, early phase or small human studies have been identified.
What is Selank?
Selank is a synthetic tuftsin derived heptapeptide analogue studied in neurobiology and anxiety related research, with published clinical and preclinical Russian literature; the catalogue label denotes the research grade peptide.
Which research context has Selank been associated with?
Selank is associated with neuroscience research including small Russian comparative clinical studies in anxiety related disorders and extensive preclinical work on receptor interactions, behavioural models, and gene expression effects in animal systems.
What documentation is available for Selank?
Selank: Batch documents are not yet linked on this site. For this synthetic tuftsin derived peptide analogue required evidence includes batch identifier and release date; identity by liquid chromatography mass spectrometry/intact mass and sequence confirmation; analytical HPLC/UPLC chromatogram with method and stated purity; peptide content, counterion and residual solvent/water declaration; and documented assay or activity measurement for release. No batch documentation is shown as available until the record for that specific item is linked and reviewed.
What determines the storage conditions for Selank?
Selank: Storage depends on the documented supplied presentation; for this synthetic tuftsin derived peptide analogue confirm dry/lyophilised versus solution form, counterion and concentration, solvent or buffer choice, pH sensitivity, container closure interactions and freeze/thaw tolerance because these factors determine degradation and aggregation behaviour. No storage instruction is shown as available until the stability record for that specific item is linked and reviewed.